Vella, Mechanism of Action of DPP-4 InhibitorsNew Insights, J
J.ChenC.GeeM.et al (2023)
IGF-1 LR3 IGF-1 LR3 is a modified form of insulin-like growth factor-1 with an arginine substitution at position 3 and a 13-amino acid N-terminal extension, designed to have reduced binding to IGF-binding proteins, which increases its free, biologically active fraction and potency
Patient experiences and weight loss results can vary, and clinical trial data for compounded versions is not available
Because of its liposomal delivery system, it may also appeal to individuals who have difficulty absorbing standard supplements
The scientific foundation for this category rests on published research demonstrating that certain gut bacteria, short-chain fatty acids, and prebiotic compounds can influence GLP-1 secretion from intestinal L-cells under controlled conditions